These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15618073)

  • 1. Temporal variability of atrial tachyarrhythmia burden in bradycardia-tachycardia syndrome patients.
    Padeletti L; Santini M; Boriani G; Botto G; Capucci A; Gulizia M; Ricci R; Spampinato A; Pieragnoli P; Warman E; Vimercati M; Grammatico A
    Eur Heart J; 2005 Jan; 26(2):165-72. PubMed ID: 15618073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal variability of atrial fibrillation in pacemaker recipients for bradycardia: implications for crossover designed trials, study sample size, and identification of responder patients by means of arrhythmia burden.
    Botto GL; Santini M; Padeletti L; Boriani G; Luzzi G; Zolezzi F; Orazi S; Proclemer A; Chiarandà G; Favale S; Solimene F; Luzi M; Vimercati M; DeSanto T; Grammatico A
    J Cardiovasc Electrophysiol; 2007 Mar; 18(3):250-7. PubMed ID: 17284291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial tachyarrhythmia recurrence temporal patterns in bradycardia patients implanted with antitachycardia pacemakers.
    Ricci R; Santini M; Padeletti L; Boriani G; Capucci A; Botto G; Gulizia M; Inama G; Galati A; Solimene F; Pepe M; Grammatico A
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):44-51. PubMed ID: 15028071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker.
    Boriani G; Bertaglia E; Carboni A; Latini R; Biffi M; Martignani C; Sciotto F; Branzi A
    Int J Cardiol; 2005 Sep; 104(1):73-6. PubMed ID: 16137513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Drug And Pace Health cliNical Evaluation (DAPHNE) study: a randomized trial comparing sotalol versus beta-blockers to treat symptomatic atrial fibrillation in patients with brady-tachycardia syndrome implanted with an antitachycardia pacemaker.
    Capucci A; Botto G; Molon G; Spampinato A; Favale S; Proclemer A; Porfilio A; Marotta T; Vimercati M; Boriani G;
    Am Heart J; 2008 Aug; 156(2):373.e1-8. PubMed ID: 18657671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device.
    Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Boriani G; Piccione G; DiGiovanni N; Colletti A; Puntrello C; Butera G; Vasco C; Vaccaro I; Scardace G; Grammatico A;
    Europace; 2006 Jul; 8(7):465-73. PubMed ID: 16798758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term reduction of atrial tachyarrhythmia recurrences in patients paced for bradycardia-tachycardia syndrome.
    Padeletti L; Santini M; Boriani G; Botto G; Gulizia M; Molon G; Luzzi G; Senatore G; Giraldi F; Zolezzi F; Pieragnoli P; Pro F; Desanto T; Grammatico A;
    Heart Rhythm; 2005 Oct; 2(10):1047-57. PubMed ID: 16188580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial.
    Gulizia M; Mangiameli S; Chiarandà G; Spadola V; Di Giovanni N; Colletti A; Bulla V; Circo A; Pensabene O; Vasquez L; Vaccaro I; Grammatico A;
    Europace; 2006 Apr; 8(4):302-5. PubMed ID: 16627459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: results of the prevention or termination (POT) trial.
    Mont L; Ruiz-Granell R; Martínez JG; Carmona JR; Fidalgo M; Cobo E; Riera M; Navarro X;
    Europace; 2008 Jan; 10(1):28-34. PubMed ID: 18199572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial tachyarrhythmia burden modelling by some electrophysiological parameters in pacemaker-recipient patients with Brady-Tachy syndrome.
    Azzolini P; Critelli G; De Giorgi V; Del Giudice GB; Ibba G; Melissano D; Scaccia A; Puglisi A
    Europace; 2006 Jul; 8(7):474-81. PubMed ID: 16798759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias.
    Saksena S; Hettrick DA; Koehler JL; Grammatico A; Padeletti L
    Am Heart J; 2007 Nov; 154(5):884-92. PubMed ID: 17967594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic and health consequences of managing bradycardia with dual-chamber compared to single-chamber ventricular pacemakers in Italy.
    Deniz HB; Caro JJ; Ward A; Moller J; Malik F
    J Cardiovasc Med (Hagerstown); 2008 Jan; 9(1):43-50. PubMed ID: 18268418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overdrive versus conventional or closed-loop rate modulation pacing in the prevention of atrial tachyarrhythmias in Brady-Tachy syndrome: on behalf of the Burden II Study Group.
    Puglisi A; Favale S; Scipione P; Melissano D; Pavia L; Ascani F; Elia M; Scaccia A; Sagone A; Castaldi B; Musacchio E; Botto GL;
    Pacing Clin Electrophysiol; 2008 Nov; 31(11):1443-55. PubMed ID: 18950302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block.
    Gillis AM; Pürerfellner H; Israel CW; Sunthorn H; Kacet S; Anelli-Monti M; Tang F; Young M; Boriani G;
    Pacing Clin Electrophysiol; 2006 Jul; 29(7):697-705. PubMed ID: 16884504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study.
    Sulke N; Silberbauer J; Boodhoo L; Freemantle N; Kamalvand K; O'Nunain S; Hildick-Smith D; Lloyd GW; Patel NR; Paul V
    Europace; 2007 Sep; 9(9):790-7. PubMed ID: 17562750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation.
    de Voogt W; van Hemel N; de Vusser P; Mairesse GH; van Mechelen R; Koistinen J; van den Bos A; Roose I; Voitk J; Yli-Mäyry S; Stockman D; El Allaf D; Tse HF; Lau CP
    Europace; 2007 Sep; 9(9):798-804. PubMed ID: 17670782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term management of atrial arrhythmias in young patients with sick sinus syndrome undergoing early operation to correct congenital heart disease.
    Drago F; Silvetti MS; Grutter G; De Santis A
    Europace; 2006 Jul; 8(7):488-94. PubMed ID: 16798761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of atrial tachyarrhythmias in pacemaker patients: results from the Balanced Evaluation of Atrial Tachyarrhythmias in Stimulated patients (BEATS) study.
    Israel CW; Neubauer H; Olbrich HG; Hartung W; Treusch S; Hohnloser SH;
    Pacing Clin Electrophysiol; 2006 Jun; 29(6):582-8. PubMed ID: 16784423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial evaluation of atrial tachyarrhythmia burden and frequency after implantation of a dual-chamber cardioverter-defibrillator.
    Schwartzman D; Gold M; Quesada A; Koehler JL; Mehra R; Euler DE;
    J Cardiovasc Electrophysiol; 2005 Jul; 16(7):708-13. PubMed ID: 16050827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of atrial antitachycardia pacing efficacy in patients affected by brady-tachy form of sick sinus syndrome and implanted with a DDDRP device.
    Boriani G; Padeletti L; Santini M; Gulizia M; Capucci A; Botto G; Ricci R; Molon G; Accogli M; Vicentini A; Biffi M; Vimercati M; Grammatico A
    J Cardiovasc Electrophysiol; 2005 Jul; 16(7):714-23. PubMed ID: 16050828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.